Appointment Follows Major Strategic Milestones Including New CEO, Key Partnerships with Waymo, Lyft, NVIDIA, and Vehicle Global Management (VGM)

NEW YORK, May 20, 2025 /PRNewswire/ — Nexar, a leader in AI-powered mobility solutions, today announced the appointment of Jayesh Patel as Chief Financial Officer. Patel will now oversee all aspects of finance, accounting, strategic planning, and corporate development as Nexar accelerates its growth trajectory.

Patel joins Nexar at a pivotal time. Over the past six months, the company has announced a series of major milestones, including the appointment of Zach Greenberger as Chief Executive Officer and Luc Vincent as Chief Research and Development Officer. Nexar has also forged strategic partnerships with Waymo to enhance safety validation for their AV models; with NVIDIA to advance the training and simulation of NVIDIA Cosmos; with Voyager Global Mobility (VGM) to expand Nexar’s connected vehicle platform across large fleets; and with HDVI to bring AI-powered solutions to insured commercial fleets.

“Nexar is entering a phase of rapid growth and strategic expansion, and building the right leadership team is essential to realizing our vision.,” said Zach Greenberger, CEO of Nexar. “Jayesh brings the financial expertise, operational discipline, and strategic mindset that will help take Nexar to the next level. With his addition, we’re deepening our ability to scale with precision and deliver lasting impact across the mobility ecosystem.”

Patel brings more than 20 years of financial and commercial leadership experience across technology, mobility, and high-growth companies including Hertz and global management consulting and technology firm ZS. He has successfully scaled strategy, finance, and commercial organizations through rapid expansion, overseen transactions, and led strategic initiatives that drive long-term value.

“Nexar is entering an exciting new chapter, and I’m proud to be a part of it,” said Patel. “The company’s momentum, leading technology platform, and talented team are undeniable. I look forward to helping Nexar build on its strong foundation and drive long-term growth and impact.”

Patel’s appointment comes as Nexar continues to expand its vision for a smarter, safer, and more connected mobility future, leveraging AI, computer vision, and the largest open network, real world driving data set in the world.

About Nexar
Nexar turns cars into vision sensors to understand the world. Its platform powers vision-connected services and apps at scale, making new vision-based applications for better driving powered by a crowd-sourced vision feed. Using anonymous, aggregated data captured from this network, Nexar has developed a portfolio of vision-based data services for the autonomous vehicle industry and public and private sector partners to make roadways safer and more efficient. More information at https://www.nexar-ai.com/.

Logo – https://mma.prnewswire.com/media/2509048/5326937/Nexar_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/nexar-names-jayesh-patel-as-chief-financial-officer-to-support-rapid-growth-and-scale-302459528.html

SOURCE Nexar

May 21 Event Includes U.S. Secretary of Commerce Howard Lutnick, U.S. Army Secretary Daniel Driscoll, Sen. Jeanne Shaheen, CIA Deputy Director Michael Ellis and Rep. John Moolenaar, Followed by Networking Reception Co-Sponsored by With Honor and May 22 ‘Wear Blue: Run to Remember’ in Honor of Memorial Day

WASHINGTON, May 20, 2025 /PRNewswire/ — Exiger, the market-leading supply chain AI company and largest provider of supply chain technology to the U.S. Government, announced “Building the Future: AI, Trade, and the New Rules of Power,” an event co-hosted by Axios. On Wednesday, May 21, 2025, at the InterContinental Hotel in Washington, DC, the invite-only event will bring together senior policymakers and industry leaders to discuss the key drivers of a resilient future. Speakers will discuss the state of global trade, the breakneck pace of innovation, and the central role of AI in securing critical supply chains.

The event will feature Fortune Global 500 CEOs, cabinet secretaries, members of Congress and other distinguished government leaders, including:

Bill Anderson, Bayer CEODaniel Driscoll, 26th U.S. Secretary of the ArmyMichael Ellis, CIA Deputy DirectorHoward Lutnick, Secretary of CommerceRep. John Moolenaar, China Select Committee Chair, House Appropriations Committee MemberSen. Jeanne Shaheen, Senate Foreign Relations Ranking Committee and Armed Services Committee MemberBrandon Daniels, Exiger CEO

The in-person and livestreamed event will feature mainstage remarks, kicking off at 5:00 pm ET, and two breakout panels, “The Future of Global Defense Industry Innovation” and “The Future of a Robust Health Care Supply Chain.” An elevated networking reception will follow formal programming, from 6:30 pm – 8:00 pm ET, hosted in partnership with cross-partisan organization With Honor.

Remarks and panels will be facilitated by:

Mike Allen, Axios Co-founderNathan Bomey, Axios Business ReporterCourtenay Brown, Axios Senior Economics ReporterColin Demarest, Axios Defense ReporterHope King, Axios Events Host & ModeratorNeil Irwin, Axios Chief Economic CorrespondentHans Nichols, Axios Political Reporter

“Building the Future: AI, Trade, and the New Rules of Power” offers a timely and critical forum to address AI’s transformative impact on the economy, defense, and the private sector. Convening experts alongside key decision makers, the event sets the stage for frank conversation and bold action from industry leaders and policymakers to accelerate the future faster. To request an invitation to the event and networking reception, visit https://axiosbuildingthefutureai.splashthat.com. Access to the livestream will be made available closer to the day of the event at https://axiosbuildingthefuture.splashthat.com/.

Following Wednesday’s event, Exiger is co-sponsoring “Wear Blue: Run to Remember” alongside With Honor and bipartisan veteran members of Congress in the For Country Caucus and With Honor Action Senate Alliance. Honoring the service and sacrifice of the American military in advance of Memorial Day, all are welcome and asked to wear blue to show their support during the run/walk on Thursday, May 22, 2025. Participants should meet at the Washington Monument for check-in beginning at 5:30 am ET.

About Exiger

Exiger is revolutionizing the way corporations, government agencies and banks navigate risk and compliance in their third-parties, supply chains and customers through its software and tech-enabled solutions. Exiger’s mission is to make the world a safer and more transparent place to succeed. Empowering its 550 customers across the globe, including 150 in the Fortune 500 and over 55 organizations across the Defense Industrial Base and government agencies, with award-winning AI technology, Exiger leads the way in ESG, cyber, financial crime, third-party and supply chain management and recently achieved FedRAMP® Moderate Authorization. Named a Leader in the Gartner® Magic Quadrant™ for Supplier Risk Management, twice selected as one of Fast Company’s ‘Brands That Matter,’ and recipient of the Third Party Risk Association’s Innovator Award, Exiger’s technology has been recognized by leading analyst evaluations and 50+ awards. Learn more at Exiger.com and follow Exiger on LinkedIn.

Press contacts:

Kody Gurfein

Chief Marketing Officer, Exiger

kgurfein@exiger.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/exiger-and-axios-host-building-the-future–ai-trade-and-the-new-rules-of-power-featuring-top-defense-and-elected-officials-302459814.html

SOURCE Exiger

Delivers pre-configured, pre-validated software that can scale with the needs of fast-growing companies

BARCELONA, Spain, May 20, 2025 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality. With standardized applications, biotechs are going live with industry-leading software in weeks and gaining a system that can scale as they expand their business. The rapid adoption of Veeva Basics signals a shift from disparate entry-level tools toward complete, best-of-breed solutions that can support biotechs today and as they grow.

Designed specifically for fast-growing companies, Veeva Basics provides pre-configured and pre-validated solutions. This enables fast deployment and adoption regardless of company size. With clinical, regulatory, and quality solutions available, Veeva is adding two new applications for biotechs:

Veeva CTMS Basics for clinical trial management, including milestones, monitoring, enrollment, issue resolution, and site communications.Veeva Submissions Publishing Basics for building, publishing, and transmitting regulatory submissions in a single system.

“More biotechs are adopting Veeva Basics in North America and Europe, driving savings in time, cost, and effort,” said Steve Harper, general manager of Veeva Basics. “Our approach to deliver pre-configured and pre-validated solutions that can go live quickly is gaining momentum, and we’re adding new clinical and regulatory solutions to meet the needs of high-growth companies. With complete cloud applications, biotechs can ensure they are always current and benefit from the latest features.”

Veeva CTMS Basics and Submissions Publishing Basics are available today in North America and Europe. Built on the proven Vault Platform, Veeva Basics applications allow customers to scale their technology infrastructure as they grow. For more on Veeva Basics, visit veeva.com/VeevaBasics.

What biotechs are saying about Veeva Basics:

“I believe Veeva Basics is a game changer, giving smaller biotech companies access to the same modern and connected applications that are typically only available to larger organizations,” said Ian Hodgson, Ph.D., chief operating officer at Corbus Pharmaceuticals, Inc. “As our company continues to grow, I am confident that Veeva’s platform can scale with us and help ensure we remain up to date as regulatory requirements evolve.”

“As we expand our studies to a larger scale, Veeva eTMF Basics gives us more control of our data and process to ensure inspection readiness,” said Joe Thornton, associate director, clinical operations at Scancell. “Having an industry-leading solution with pre-configured best practices as our foundation for trials will help drive speed and innovation as we continue to develop novel immunotherapies.”

“The global support and training provided with Veeva Basics helps us gain maximum value from Veeva’s industry solution,” said Rebecca Deng, Ph.D., associate director, regulatory affairs and QA systems at Terns Pharmaceuticals. “With a simple path to go live and validation, Veeva Basics has delivered significant time and resource savings.”

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva’s products and services and the expected results or benefits from use of our products and services, including certain of our new solutions and applications that are still under development or not generally available. These statements are based on our current expectations. Actual results, availability, and any future events relating to these products and services could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 9 and 10), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:

Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com

View original content:https://www.prnewswire.co.uk/news-releases/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality-302460181.html